AKT1 and central nervous system cancer: Cyclin‐dependent kinase‐like 5 promotes the proliferation, migration, drug resistance and invasion of glioma cells, which contributes to glioma growth in vivo by stimulating the phosphoinositide 3‐kinase/AKT axis.